Leerink Partnrs Analysts Decrease Earnings Estimates for RNA
Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) – Equities research analysts at Leerink Partnrs dropped their FY2026 earnings per share estimates for Avidity Biosciences in a research note issued on Monday, June 9th. Leerink Partnrs analyst J. Schwartz now forecasts that the biotechnology company will post earnings of ($5.06) per share for the year, down […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) – Equities research analysts at Leerink Partnrs dropped their FY2026 earnings per share estimates for Avidity Biosciences in a research note issued on Monday, June 9th. Leerink Partnrs analyst J. Schwartz now forecasts that the biotechnology company will post earnings of ($5.06) per share for the year, down […]
